Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rhesoglobin
- Development stage
- Phase 4
- Lead developer
- Biopharma Plasma
- Modality
- Antibody-Based Therapeutics
- Administration
- Intramuscular
01
Overview
Rhesoglobin is a plasma-derived biologic containing human anti-D (Rh) immunoglobulin, developed by Biopharma Plasma LLC. It is indicated for the prevention of Rh isoimmunization (Rh sensitization) in Rh-negative pregnant women. The drug works by binding to RhD-positive fetal erythrocytes that may enter the maternal circulation during pregnancy or delivery, effectively masking the RhD antigen from the mother's immune system. This prevents the formation of maternal anti-D antibodies, thereby protecting future Rh-positive fetuses from hemolytic disease of the fetus and newborn (HDFN). It is typically administered as a 300 mcg dose both antenatally (at 28 weeks) and postnatally (within 72 hours of delivery).
- Brand names
- Rhesoglobin
- Other names
- human anti-D (Rh) immunoglobulinanti-D (Rho) immunoglobulin
Beyond the preview
Go deeper on Rhesoglobin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rhesoglobin.